Cichoz-Lach Halina, Partycka Jadwiga, Nesina Irina, Celinski Krzysztof, Slomka Maria, Wojcierowski Jacek
Department of Gastroenterology, Medical University of Lublin, ul. Sikorskiego 1/75, PL-20-814 Lublin, Poland.
Scand J Gastroenterol. 2007 Apr;42(4):493-8. doi: 10.1080/00365520600965723.
To investigate the effects of ADH and ALDH gene polymorphism on the development of alcoholism, alcohol liver cirrhosis and alcohol chronic pancreatitis among Polish individuals.
We determined the allele and genotype of ADH2, ADH3 and ALDH2 in 198 subjects: 57 with alcohol cirrhosis, 44 with alcohol chronic pancreatitis and 43 "healthy alcoholics"; 54 healthy non-drinkers served as controls. Genotyping was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method on white cell DNA.
In the population examined the ADH21 allele frequency was 97.97%. The tests did not show the ADH23 allele. The ADH31 allele frequency was 57.07%. The ADH21 and the ADH31 alleles were statistically more common among patients who abuse alcohol in comparison with the controls. The ADH22 allele was not detected in any of the patients with chronic alcohol pancreatitis. The ADH21/1 and the ADH31/1 genotypes were statistically significantly more common among the patients who abuse alcohol than in the control group. All patients were ALDH21/1 homozygotic. Patients with the ADH31 allele and the ADH31/1 genotype started to abuse alcohol significantly earlier in comparison to the patients with the ADH32 allele and the ADH3*2 /*2 genotype.
In the Polish population examined, the ADH31 allele and the ADH31/1 genotype are conducive to the development of alcoholism, alcohol liver cirrhosis and alcohol chronic pancreatitis. However, the ADH22 allele is likely to protect against these conditions. Genetic polymorphism of ALDH2 shows no correlation with alcohol addiction or alcohol cirrhosis and alcohol chronic pancreatitis. The ADH31 allele and the ADH31/*1 genotype are conducive to alcohol abuse starting at a younger age.
研究乙醇脱氢酶(ADH)和乙醛脱氢酶(ALDH)基因多态性对波兰人群酒精中毒、酒精性肝硬化及酒精性慢性胰腺炎发病的影响。
我们测定了198名受试者的ADH2、ADH3及ALDH2的等位基因和基因型,其中57例为酒精性肝硬化患者,44例为酒精性慢性胰腺炎患者,43例为“健康酗酒者”;54名健康不饮酒者作为对照。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对白细胞DNA进行基因分型。
在所检测的人群中,ADH21等位基因频率为97.97%。未检测到ADH23等位基因。ADH31等位基因频率为57.07%。与对照组相比,ADH21和ADH31等位基因在酗酒患者中在统计学上更为常见。在任何酒精性慢性胰腺炎患者中均未检测到ADH22等位基因。ADH21/1和ADH31/1基因型在酗酒患者中在统计学上显著多于对照组。所有患者均为ALDH21/1纯合子。与具有ADH32等位基因和ADH32/2基因型的患者相比,具有ADH31等位基因和ADH3*1/*1基因型的患者开始酗酒的时间明显更早。
在所检测的波兰人群中,ADH31等位基因和ADH31/1基因型有利于酒精中毒、酒精性肝硬化及酒精性慢性胰腺炎的发生。然而,ADH22等位基因可能对这些疾病具有保护作用。ALDH2的基因多态性与酒精成瘾、酒精性肝硬化及酒精性慢性胰腺炎无相关性。ADH31等位基因和ADH31/*1基因型有利于在较年轻时开始酗酒。